Last month, Australis Capital Inc., operating as AUDACIOUS (CSE: AUSA) (OTC: AUSAF) announced plans to raise $15 million and retained DelMorgan & Co. to assist with the process.
We believe the timing of a capital raise could not come at a better time as Audacious plans to use the capital to expand its footprint and further accelerate growth. DelMorgan has a proven track record at raising capital for cannabis companies and we are favorable on the caliber of the firm that was retained. What we particularly like is that this is a renowned U.S. house working with a CSE listed company, not something we have seen a lot of, which we believe is a ringing endorsement of both the AUSA story and its management team.
Audacious CEO Terry Booth reported that the company is analyzing a variety of potential transactions and partnerships. The capital will help Audacious capitalize on strategic opportunities and will help bring the business to the next level. Going by the calibre and strategic fit of transactions the Company has announced to date, we believe that any new opportunities Audacious intends to capitalize on will further accelerate growth, a side of the story we believe is not yet factored into ther market valuation of the company.
So far this year, Audacious has been nothing short of an execution story with several acquisitions completed that have already proven to be accretive to the business. With the capital, the company can find additional synergies and value between the assets that it has acquired.
We have been following Audacious since inception and are bullish on its new growth strategy. We are of the opinion that the combination of ALPS, Green Therapeutics (GT), LOOS and Herbs, has enhanced the company’s growth profile and has provided the business with several potential catalysts.
Audacious’s management team believes the sum of the parts of the business is more valuable than the standalone company and has taken synergistic approach to make this apparent to the market. We believe the market is currently discounting the growth prospects that are associated with the business and our readers should be aware of our view.
Australis is led by a world-class management team that has a proven track record of success in the cannabis industry. We are favorable on the human capital that is associated with the business and believe the recent additions to the team will prove to beneficial over the long-term.
The management team has been working tirelessly and executing flawlessly on a unique strategy to create a global leader in cannabis operations and brands. We are bullish on the company’s leverage to the U.S. market as well as the assets that are owned by it. We are of the opinion that Audacious is in the early innings of a major growth cycle and is an opportunity that is trading for a discount when compared to its peers.
If you are interested in learning more about Audacious’ long-term growth strategy, please send an email to firstname.lastname@example.org with the subject “Audacious” to be added to our distribution list.
Pursuant to an agreement between StoneBridge Partners LLC and Australis Capital Inc. we have been hired for a period of 180 days beginning September 13, 2021 and ending to publicly disseminate information about (AUSA) including on the Website and other media including Facebook and Twitter. We are being paid $6,000 per month (AUSA) for or were paid “ZERO” shares of unrestricted or restricted common shares. We plan to sell the “ZERO” shares of (AUSA) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (AUSA) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.